New European HIV Treatment Guidelines Recommend Boosted Invirase® As A First Choice Treatment For Patients Starting Therapy
20th Nov 2005, 15:03 GMT
New European Guidelines for the Clinical Management and Treatment of HIV Infected Adults published today recommend boosted Invirase® (saquinavir mesylate) as a first choice protease inhibitor for patients starting antiretroviral treatment.1 A twice daily dose of saquinavir/ritonavir 1000/100 mg in combination with other antiretrovirals offers physicians and patients proven effective control of the HIV virus... click link for more info.
New European HIV Treatment Guidelines Recommend Boosted Invirase® As A First Choice Treatment For Patients Starting Therapy related news:
- New European HIV Treatment Guidelines Recommend Boosted Invirase(R) as a First Choice Treatment for Patients Starting Therapy — mysan.de
- European HIV treatment guidelines updated — OnMedica Latest News
- Emtricitabine, a New Antiretroviral Agent with Activity against HIV and Hepatitis B Virus — Clin Infect Dis Latest Articles
- Patients more willing to consider self-injectable HIV therapy than many physicians anticipate, study — Medical News Today RSS/XML Feed
- HIV patients gain wider access to innovative technology — Pharmaceutical Business Review Online
- Symbicort Maintenance and Reliever Therapy is Highly Effective Compared with Any Dose of Seretide — Medical News Today RSS/XML Feed
- New Therapy for Malaria Treatment — AllAfrica News: Ghana
- PanAfrica: New Therapy for Malaria Treatment — AllAfrica News: Health and Medicine
- New Study Shows Patients More Willing to Consider Self-Injectable HIV Therapy Than Many Physicians Anticipate — Presseportal.de Wirtschaft
- Effect of HIV-1 Infection on Antimalarial Treatment Outcomes in Uganda: A Population-Based Study — J Infect Dis Latest Articles
Latest news from Medical News Today RSS/XML Feed:
- Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines
- Common Cause Of Heart Disease, Diabetes May Be Treatable With Malaria Drug
- Two Nerve Cells In Direct Contact
- Value Of 'Helper' Compound In Treating Some Leukemias
- Internists Take Home Several National Awards At AAMC Annual Meeting
- Most Canadian Med School Grads Lack Basic Surgical Skills
- ACP's Electronic Medical Resource Ranked No. 1 Evidence-based Tool By MLA's South Central Chapter
- University Of Illinois Scientist Helping Processors Keep E. Coli Out Of Meat
- American Thoracic Society Publishes New Statement On Hepatotoxicity Of Antituberculosis Therapy
- Neural Networking Nanotubes